IGF-1 DES

$57.00

You’ll be briefly redirected to Link Money, our secure ACH payment partner, to connect your bank and complete payment.– Your bank login is never visible to or stored by us – Encrypted, bank-level security – A standard, trusted payment process

Aion Aminos

Precision Peptides for Advanced Research

IGF-1 DES is a truncated analog of insulin like growth factor 1 consisting of the first 67 amino acids of the native sequence. This IGF-1 peptide is a modified growth factor studied in laboratory environments for its enhanced receptor affinity compared with regular IGF 1 due to reduced interaction with IGF binding proteins. In scientific research, IGF DES is examined for its interaction with the IGF 1 receptor, which regulates signaling pathways associated with cell proliferation, protein synthesis, and cellular growth. Investigations often focus on the biological communication networks influenced by growth hormone, insulin, and insulin like growth factor signaling pathways. Academic literature frequently compares IGF-1 DES with other analogs such as IGF 1 LR3 and mechano growth factor in experimental systems examining localized signaling responses within muscle cells and muscle tissue. These studies often analyze pathways associated with muscle growth, muscle hypertrophy, and satellite cell activation in cellular models. This compound is supplied as a stable, research-grade lyophilized powder for controlled laboratory investigation.

Research Applications (Laboratory Use Only)

In laboratory environments, IGF-1 DES is studied as a growth factor involved in cellular signaling pathways related to cellular growth and metabolic regulation. Research commonly explores how the peptide interacts with the IGF 1 receptor to influence downstream signaling pathways associated with protein synthesis, cell proliferation, and cellular communication networks.

Experimental models often investigate how insulin like growth factor signaling interacts with pathways influenced by growth hormone and insulin. These studies frequently examine cellular mechanisms related to muscle growth, muscle tissue development, and structural adaptation in muscle cells.

Scientific publications also reference experimental frameworks examining satellite cell activation, muscle hypertrophy, and signaling pathways involved in recovery and cellular growth processes in laboratory systems. Additional research models explore theoretical frameworks related to tissue regeneration, metabolic signaling, and cellular responses associated with endocrine communication networks.

Some research literature discusses potential links between IGF 1 levels, insulin sensitivity, metabolic signaling, and pathways associated with fat loss or metabolic adaptation. These references remain limited strictly to laboratory research contexts and do not represent approved medical or performance applications.

Key Features

  • Compound Name: IGF-1 DES (truncated IGF 1 analog)

  • Synthetic IGF 1 peptide derived from native IGF 1 sequence

  • Consists of 67 amino acids from the insulin like growth factor protein

  • Investigated in research involving growth factor signaling pathways

  • Studied for interaction with the IGF 1 receptor and related signaling systems

  • Explored in research examining cell proliferation, protein synthesis, and cellular growth

  • Scientific literature references models analyzing muscle growth, muscle tissue, and muscle cells

  • Investigated in research involving muscle hypertrophy and satellite cell activation pathways

  • Studied in metabolic models involving insulin sensitivity, insulin, and endocrine signaling

  • Supplied as a research-grade peptide powder with 99 purity (HPLC)

  • Packaged in a sterile vial for laboratory handling

  • Distributed for research purposes within the United States
  • Not intended for supplementation, post cycle therapy, or human consumption

Frequently Asked Questions

IGF-1 DES is a truncated IGF 1 analog derived from insulin like growth factor 1. It is studied in laboratory environments for its interaction with the IGF 1 receptor and growth-related signaling pathways.

Both compounds are modified peptides derived from insulin like growth factor. IGF 1 LR3 contains structural changes that extend circulation time, while IGF-1 DES is a truncated variant with reduced interaction with IGF binding proteins in research models.

Scientific studies frequently examine IGF DES in cellular models exploring growth factor signaling, cell proliferation, protein synthesis, and biological processes associated with muscle growth and cellular growth pathways.

No. This peptide is sold strictly for research purposes and is not intended for human consumption, supplementation, ortherapeutic use.

More Peptides